COMPASS HOUSE MEDICAL CENTRES — All Prescriptions & Medications — Page 14
Practice Code: L83055 | BRIXHAM, TQ5 9TF
Showing results 651-700 of 727
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Exenatide | 13 | 76 | £1.4K | -25.9% ▼ |
| Indoramin | 13 | 728 | £602 | -14.5% ▼ |
| Potassium citrate | 13 | 2,600 | £30 | +53.2% ▲ |
| Tablets/capsules micronutrient supplement (0913282) | 13 | 364 | £236 | +24.1% ▲ |
| Powder 1.3 kcal/ml milkshake pre-thickened (0913671) | 13 | 452 | £941 | +73.5% ▲ |
| Diclofenac sodium | 13 | 1,300 | £69 | +22.2% ▲ |
| Tafluprost and timolol | 13 | 600 | £290 | -32.3% ▼ |
| Imiquimod | 13 | 148 | £600 | +82.9% ▲ |
| Mupirocin | 13 | 195 | £70 | +40.0% ▲ |
| Other individually formulated bought in preparations | 13 | 174 | £141 | -60.2% ▼ |
| 13 | 1,000 | £143 | -66.6% ▼ | |
| 13 | 14 | £105 | +109.6% ▲ | |
| 13 | 630 | £461 | +24.9% ▲ | |
| 13 | 390 | £1.2K | +27.6% ▲ | |
| 13 | 280 | £1.9K | +28.0% ▲ | |
| Sodium cromoglicate | 12 | 2,400 | £3.6K | +16.0% ▲ |
| Linaclotide | 12 | 336 | £428 | -34.3% ▼ |
| Nadolol | 12 | 644 | £425 | +18.7% ▲ |
| Olmesartan medoxomil/amlodipine | 12 | 672 | £387 | -9.0% ▼ |
| Ciclesonide | 12 | 19 | £670 | -18.5% ▼ |
| Sulpiride | 12 | 672 | £56 | -55.2% ▼ |
| Saxagliptin | 12 | 336 | £360 | -64.1% ▼ |
| Dapagliflozin/metformin | 12 | 672 | £417 | -72.7% ▼ |
| Estradiol valerate | 12 | 980 | £82 | -38.6% ▼ |
| Sodium feredetate | 12 | 5,120 | £146 | -58.1% ▼ |
| Vitamin A | 12 | 672 | £65 | +6.4% ▲ |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 12 | 10.3K | £1.0K | -54.8% ▼ |
| Powder 20g protein equivalent (0913205) | 12 | 1,011 | £13.5K | +51.9% ▲ |
| Powder 1.7 kcal/ml milkshake pre-thickened (0913671) | 12 | 336 | £712 | +42.7% ▲ |
| Pilocarpine hydrochloride | 12 | 120 | £303 | +16.9% ▲ |
| Other eye tear/lubricant/astringent preparations | 12 | 1,600 | £121 | +9.7% ▲ |
| 12 | 72 | £209 | +50.1% ▲ | |
| 12 | 200 | £475 | -31.9% ▼ | |
| 12 | 28 | £999 | +133.8% ▲ | |
| 12 | 960 | £3.3K | +19.6% ▲ | |
| 12 | 1,250 | £110 | +88.7% ▲ | |
| 12 | 280 | £1.8K | -6.1% ▼ | |
| Nizatidine | 11 | 616 | £1.4K | -68.0% ▼ |
| Rabeprazole sodium | 11 | 700 | £85 | -78.7% ▼ |
| Phosphates (Rectal) | 11 | 146 | £503 | -10.0% ▼ |
| Omega-3-acid ethyl esters | 11 | 1,232 | £595 | -47.9% ▼ |
| Umeclidinium bromide | 11 | 11 | £288 | -82.2% ▼ |
| Daridorexant | 11 | 330 | £439 | -15.8% ▼ |
| Valproic acid | 11 | 1,320 | £309 | -24.8% ▼ |
| Phenobarbital | 11 | 1,288 | £208 | -64.2% ▼ |
| Relugolix | 11 | 386 | £1.1K | +279.8% ▲ |
| RtS 2 kcal/ml m/sk high protein, high energy+fibre (0913011) | 11 | 46.2K | £561 | -7.7% ▼ |
| Tablets OTC glucose for diabetic hypo treatment (0913541) | 11 | 570 | £32 | -26.8% ▼ |
| Loteprednol etabonate | 11 | 65 | £68 | +18.9% ▲ |
| Nepafenac | 11 | 55 | £156 | +77.1% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.